Clinical Research Directory

Early Beta Blocker Administration in STEMI Patients With SCAI B Status

Sponsor: Tel-Aviv Sourasky Medical Center

Summary

This study is looking at how a medication called beta-blockers (metoprolol) affects patients with a heart attack (STEMI) who are in the cardiac intensive care unit. When patients are admitted to the unit, they will be randomly placed in one of two groups. One group will get the metoprolol medication, and the other will receive a placebo (a harmless pill that looks like the real medication). All other treatments will be the same for both groups. During the study, which is 72 hours long, patients will be monitored for blood pressure, heart rate, and lactate levels alterations. The main goal is to see if the medication helps improve patients condition or prevent it from getting worse. patients safety is a top priority, and if needed, the doctors can stop the study at any time if there are concerns.

Official title: Early Beta-Blocker Administration in Patients With ST Segment Elevation Myocardial Infraction and SCAI B Status

Key Details

Conditions

Interventions

Locations (1)